Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 4477 to 4486 of 4486 entries
Sorted by: Best Match Show Resources per page
Paraprotein interference of automated total bilirubin measurement.

Pathology

Melville A, Thomas SDC.
PMID: 34330525
Pathology. 2021 Jul 27; doi: 10.1016/j.pathol.2021.04.010. Epub 2021 Jul 27.

No abstract available.

Cite
Melville A, Thomas SDC. Paraprotein interference of automated total bilirubin measurement. Pathology. 2021;doi: 10.1016/j.pathol.2021.04.010.
Melville, A., & Thomas, S. D. C. (2021). Paraprotein interference of automated total bilirubin measurement. Pathology, . https://doi.org/10.1016/j.pathol.2021.04.010
Melville, Anna, and Thomas, Sunethra Devika C. "Paraprotein interference of automated total bilirubin measurement." Pathology vol. (2021). doi: https://doi.org/10.1016/j.pathol.2021.04.010
Melville A, Thomas SDC. Paraprotein interference of automated total bilirubin measurement. Pathology. 2021 Jul 27; doi: 10.1016/j.pathol.2021.04.010. Epub 2021 Jul 27. PMID: 34330525.
Copy Download .nbib Format: NLM
Long-term mortality predictors of ICU fungaemia.

Epidemiology and infection

Xie P, Wang W, Dong M.
PMID: 34658330
Epidemiol Infect. 2021 Oct 18;149:e241. doi: 10.1017/S0950268821002235.

Bloodstream fungal infections have a high mortality rate. There is little data about the long-term mortality rate of fungaemia.This study aimed to explore the mortality of fungaemia and the influencing factors associated with death. In total, 204 intensive care...

Cite
Xie P, Wang W, Dong M. Long-term mortality predictors of ICU fungaemia. Epidemiol Infect. 2021;149:e241doi: 10.1017/S0950268821002235.
Xie, P., Wang, W., & Dong, M. (2021). Long-term mortality predictors of ICU fungaemia. Epidemiology and infection, 149e241. https://doi.org/10.1017/S0950268821002235
Xie, Peng, et al. "Long-term mortality predictors of ICU fungaemia." Epidemiology and infection vol. 149 (2021): e241. doi: https://doi.org/10.1017/S0950268821002235
Xie P, Wang W, Dong M. Long-term mortality predictors of ICU fungaemia. Epidemiol Infect. 2021 Oct 18;149:e241. doi: 10.1017/S0950268821002235. PMID: 34658330; PMCID: PMC8637461.
Copy Download .nbib Format: NLM
Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure.

Journal of family medicine and primary care

Manik AH, Malakar D, Noor-E-Alam SM, Mahtab MA, Das DC, Mamun AA, Khan S, Akbar MF, Rahman Z, Rahman S.
PMID: 34322441
J Family Med Prim Care. 2021 Jun;10(6):2376-2380. doi: 10.4103/jfmpc.jfmpc_2300_20. Epub 2021 Jul 02.

INTRODUCTION: HBV is major health problem globally due to complications, including ACLF, cirrhosis and hepa¬tocellular carcinoma. ACLF due to exacerbation of CHB is associate with 30%-70% mortality. Reduction of HBV-DNA is therefore a target of therapy in ACLF-B.METHODS: Patients...

Cite
Manik AH, Malakar D, Noor-E-Alam SM, et al. Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure. J Family Med Prim Care. 2021;10(6):2376-2380doi: 10.4103/jfmpc.jfmpc_2300_20.
Manik, A. H., Malakar, D., Noor-E-Alam, S. M., Mahtab, M. A., Das, D. C., Mamun, A. A., Khan, S., Akbar, M. F., Rahman, Z., & Rahman, S. (2021). Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure. Journal of family medicine and primary care, 10(6), 2376-2380. https://doi.org/10.4103/jfmpc.jfmpc_2300_20
Manik, Abul H, et al. "Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure." Journal of family medicine and primary care vol. 10,6 (2021): 2376-2380. doi: https://doi.org/10.4103/jfmpc.jfmpc_2300_20
Manik AH, Malakar D, Noor-E-Alam SM, Mahtab MA, Das DC, Mamun AA, Khan S, Akbar MF, Rahman Z, Rahman S. Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure. J Family Med Prim Care. 2021 Jun;10(6):2376-2380. doi: 10.4103/jfmpc.jfmpc_2300_20. Epub 2021 Jul 02. PMID: 34322441; PMCID: PMC8284233.
Copy Download .nbib Format: NLM
Hemorrhagic cholecystitis from isolated gallbladder injury following blunt abdominal trauma: An unusual case report.

International journal of surgery case reports

Wiebe I, Baig Z, Sothilingam N.
PMID: 34915440
Int J Surg Case Rep. 2021 Dec 11;90:106680. doi: 10.1016/j.ijscr.2021.106680. Epub 2021 Dec 11.

INTRODUCTION AND IMPORTANCE: Gallbladder contusion after blunt abdominal trauma is a rare event that presents with diagnostic challenges. There is no clear evidence supporting conservative or surgical management of gallbladder contusion injuries, especially when they present in isolation. Here,...

Cite
Wiebe I, Baig Z, Sothilingam N. Hemorrhagic cholecystitis from isolated gallbladder injury following blunt abdominal trauma: An unusual case report. Int J Surg Case Rep. 2021;90:106680doi: 10.1016/j.ijscr.2021.106680.
Wiebe, I., Baig, Z., & Sothilingam, N. (2021). Hemorrhagic cholecystitis from isolated gallbladder injury following blunt abdominal trauma: An unusual case report. International journal of surgery case reports, 90106680. https://doi.org/10.1016/j.ijscr.2021.106680
Wiebe, Isaac, et al. "Hemorrhagic cholecystitis from isolated gallbladder injury following blunt abdominal trauma: An unusual case report." International journal of surgery case reports vol. 90 (2021): 106680. doi: https://doi.org/10.1016/j.ijscr.2021.106680
Wiebe I, Baig Z, Sothilingam N. Hemorrhagic cholecystitis from isolated gallbladder injury following blunt abdominal trauma: An unusual case report. Int J Surg Case Rep. 2021 Dec 11;90:106680. doi: 10.1016/j.ijscr.2021.106680. Epub 2021 Dec 11. PMID: 34915440; PMCID: PMC8683717.
Copy Download .nbib Format: NLM
Repeatedly in Rhabdomyolysis.

Pediatric emergency care

Gooch C, Dean SJ, Marzullo L.
PMID: 32205805
Pediatr Emerg Care. 2021 Dec 01;37(12):e1759-e1760. doi: 10.1097/PEC.0000000000002079.

ABSTRACT: Repeated presentations of a rare symptom in a patient should make a physician stop and evaluate for rare conditions. This is a report of a teenager with multiple episodes of rhabdomyolysis and weakness. He was eventually diagnosed as...

Cite
Gooch C, Dean SJ, Marzullo L. Repeatedly in Rhabdomyolysis. Pediatr Emerg Care. 2021;37(12):e1759-e1760doi: 10.1097/PEC.0000000000002079.
Gooch, C., Dean, S. J., & Marzullo, L. (2021). Repeatedly in Rhabdomyolysis. Pediatric emergency care, 37(12), e1759-e1760. https://doi.org/10.1097/PEC.0000000000002079
Gooch, Catherine, et al. "Repeatedly in Rhabdomyolysis." Pediatric emergency care vol. 37,12 (2021): e1759-e1760. doi: https://doi.org/10.1097/PEC.0000000000002079
Gooch C, Dean SJ, Marzullo L. Repeatedly in Rhabdomyolysis. Pediatr Emerg Care. 2021 Dec 01;37(12):e1759-e1760. doi: 10.1097/PEC.0000000000002079. PMID: 32205805.
Copy Download .nbib Format: NLM
Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes.

Clinical and translational science

Deiteren A, Coenen E, Lenders S, Verwilst P, Mannaert E, Rasschaert F.
PMID: 34378856
Clin Transl Sci. 2021 Nov;14(6):2450-2460. doi: 10.1111/cts.13113. Epub 2021 Aug 11.

Protocols for clinical trials describe inclusion and exclusion criteria based on general and compound-specific considerations to ensure subject safety and data quality. In phase I clinical trials, healthy volunteers (HVs) are screened against these criteria that often specify predefined...

Cite
Deiteren A, Coenen E, Lenders S, et al. Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes. Clin Transl Sci. 2021;14(6):2450-2460doi: 10.1111/cts.13113.
Deiteren, A., Coenen, E., Lenders, S., Verwilst, P., Mannaert, E., & Rasschaert, F. (2021). Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes. Clinical and translational science, 14(6), 2450-2460. https://doi.org/10.1111/cts.13113
Deiteren, Annemie, et al. "Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes." Clinical and translational science vol. 14,6 (2021): 2450-2460. doi: https://doi.org/10.1111/cts.13113
Deiteren A, Coenen E, Lenders S, Verwilst P, Mannaert E, Rasschaert F. Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes. Clin Transl Sci. 2021 Nov;14(6):2450-2460. doi: 10.1111/cts.13113. Epub 2021 Aug 11. PMID: 34378856; PMCID: PMC8604224.
Copy Download .nbib Format: NLM
Liver function as a predictor of mortality in COVID-19: A retrospective study.

Annals of hepatology

Salık F, Uzundere O, Bıçak M, Akelma H, Akgündüz M, Korhan Z, Kandemir D, Kaçar CK.
PMID: 34624543
Ann Hepatol. 2021 Oct 06;100553. doi: 10.1016/j.aohep.2021.100553. Epub 2021 Oct 06.

INTRODUCTION AND OBJECTIVES: In many studies, varying degrees of liver damage have been reported in more than half of the COVID-19 patients. The aim of this study is to determine the effect of liver biochemical parameters abnormality on mortality...

Cite
Salık F, Uzundere O, Bıçak M, et al. Liver function as a predictor of mortality in COVID-19: A retrospective study. Ann Hepatol. 2021;100553doi: 10.1016/j.aohep.2021.100553.
Salık, F., Uzundere, O., Bıçak, M., Akelma, H., Akgündüz, M., Korhan, Z., Kandemir, D., & Kaçar, C. K. (2021). Liver function as a predictor of mortality in COVID-19: A retrospective study. Annals of hepatology, 100553. https://doi.org/10.1016/j.aohep.2021.100553
Salık, Fikret, et al. "Liver function as a predictor of mortality in COVID-19: A retrospective study." Annals of hepatology vol. (2021): 100553. doi: https://doi.org/10.1016/j.aohep.2021.100553
Salık F, Uzundere O, Bıçak M, Akelma H, Akgündüz M, Korhan Z, Kandemir D, Kaçar CK. Liver function as a predictor of mortality in COVID-19: A retrospective study. Ann Hepatol. 2021 Oct 06;100553. doi: 10.1016/j.aohep.2021.100553. Epub 2021 Oct 06. PMID: 34624543; PMCID: PMC8492360.
Copy Download .nbib Format: NLM
A Rare Case of Acute Liver Failure Secondary to Diffuse Hepatic Infiltration of Small Cell Neuroendocrine Carcinoma.

Frontiers in oncology

Yan P, Liu Y, Wang Q, Chen X.
PMID: 33747928
Front Oncol. 2021 Mar 04;11:616337. doi: 10.3389/fonc.2021.616337. eCollection 2021.

BACKGROUND: Malignant liver infiltration is an uncommon cause of acute liver failure (ALF) and has rarely been reported.CASE PRESENTATION: We present a patient with progressive jaundice and dissociation of bilirubin and aminotransferases, who had no history of relevant liver...

Cite
Yan P, Liu Y, Wang Q, et al. A Rare Case of Acute Liver Failure Secondary to Diffuse Hepatic Infiltration of Small Cell Neuroendocrine Carcinoma. Front Oncol. 2021;11:616337doi: 10.3389/fonc.2021.616337.
Yan, P., Liu, Y., Wang, Q., & Chen, X. (2021). A Rare Case of Acute Liver Failure Secondary to Diffuse Hepatic Infiltration of Small Cell Neuroendocrine Carcinoma. Frontiers in oncology, 11616337. https://doi.org/10.3389/fonc.2021.616337
Yan, Ping, et al. "A Rare Case of Acute Liver Failure Secondary to Diffuse Hepatic Infiltration of Small Cell Neuroendocrine Carcinoma." Frontiers in oncology vol. 11 (2021): 616337. doi: https://doi.org/10.3389/fonc.2021.616337
Yan P, Liu Y, Wang Q, Chen X. A Rare Case of Acute Liver Failure Secondary to Diffuse Hepatic Infiltration of Small Cell Neuroendocrine Carcinoma. Front Oncol. 2021 Mar 04;11:616337. doi: 10.3389/fonc.2021.616337. eCollection 2021. PMID: 33747928; PMCID: PMC7969992.
Copy Download .nbib Format: NLM
Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19).

International journal of general medicine

Huang D, Yang H, Yu H, Wang T, Chen Z, Liang Z, Yao R.
PMID: 34456583
Int J Gen Med. 2021 Aug 21;14:4711-4721. doi: 10.2147/IJGM.S326204. eCollection 2021.

PURPOSE: We sought to explore the prognostic value of blood urea nitrogen (BUN) to serum albumin ratio (BAR) and further develop a prediction model for critical illness in COVID-19 patients.PATIENTS AND METHODS: This was a retrospective, multicenter, observational study...

Cite
Huang D, Yang H, Yu H, et al. Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19). Int J Gen Med. 2021;14:4711-4721doi: 10.2147/IJGM.S326204.
Huang, D., Yang, H., Yu, H., Wang, T., Chen, Z., Liang, Z., & Yao, R. (2021). Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19). International journal of general medicine, 144711-4721. https://doi.org/10.2147/IJGM.S326204
Huang, Dong, et al. "Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19)." International journal of general medicine vol. 14 (2021): 4711-4721. doi: https://doi.org/10.2147/IJGM.S326204
Huang D, Yang H, Yu H, Wang T, Chen Z, Liang Z, Yao R. Blood Urea Nitrogen to Serum Albumin Ratio (BAR) Predicts Critical Illness in Patients with Coronavirus Disease 2019 (COVID-19). Int J Gen Med. 2021 Aug 21;14:4711-4721. doi: 10.2147/IJGM.S326204. eCollection 2021. PMID: 34456583; PMCID: PMC8387643.
Copy Download .nbib Format: NLM
ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C.

International journal of general medicine

Song S, Zhang Y, Qiao X, Duo Y, Xu J, Peng Z, Zhang J, Chen Y, Nie X, Sun Q, Yang X, Wang A, Lu Z, Sun W, Fu Y, Dong Y, Yuan T, Zhao W.
PMID: 35023950
Int J Gen Med. 2022 Jan 05;15:115-121. doi: 10.2147/IJGM.S332946. eCollection 2022.

OBJECTIVE: This study aimed to find the association between alanine transaminase-to-aspartate aminotransferase ratio (ALT/AST) and the incidence of gestational diabetes mellitus (GDM).METHODS: A total of 1128 pregnant women were included in this prospective, double-center, observational cohort study. ALT, AST...

Cite
Song S, Zhang Y, Qiao X, et al. ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C. Int J Gen Med. 2022;15:115-121doi: 10.2147/IJGM.S332946.
Song, S., Zhang, Y., Qiao, X., Duo, Y., Xu, J., Peng, Z., Zhang, J., Chen, Y., Nie, X., Sun, Q., Yang, X., Wang, A., Lu, Z., Sun, W., Fu, Y., Dong, Y., Yuan, T., & Zhao, W. (2022). ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C. International journal of general medicine, 15115-121. https://doi.org/10.2147/IJGM.S332946
Song, Shuoning, et al. "ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C." International journal of general medicine vol. 15 (2022): 115-121. doi: https://doi.org/10.2147/IJGM.S332946
Song S, Zhang Y, Qiao X, Duo Y, Xu J, Peng Z, Zhang J, Chen Y, Nie X, Sun Q, Yang X, Wang A, Lu Z, Sun W, Fu Y, Dong Y, Yuan T, Zhao W. ALT/AST as an Independent Risk Factor of Gestational Diabetes Mellitus Compared with TG/HDL-C. Int J Gen Med. 2022 Jan 05;15:115-121. doi: 10.2147/IJGM.S332946. eCollection 2022. PMID: 35023950; PMCID: PMC8743491.
Copy Download .nbib Format: NLM
Showing 4477 to 4486 of 4486 entries